A Clinical Trial to Test How Well Two Drugs, QAW039 and Montelukast Work Both Individually and Together, to Target Allergic Rhinitis Using an Environmental Exposure Chamber

NCT01804400 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

188

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergic Rhinitis

Interventions

DRUG: QAW039
DRUG: Montelukast
DRUG: Placebo

Sponsor

Novartis Pharmaceuticals